Neel BG - Search Results

1

Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer.

Masiello D, Mohi MG, McKnight NC, Smith B, Neel BG, Balk SP, Bubley GJ. Masiello D, et al. Among authors: neel bg. Cancer Biol Ther. 2007 Feb;6(2):195-201. doi: 10.4161/cbt.6.2.3588. Epub 2007 Feb 7. Cancer Biol Ther. 2007. PMID: 17218776 Free article.

2

Combination of rapamycin and protein tyrosine kinase (PTK) inhibitors for the treatment of leukemias caused by oncogenic PTKs.

Mohi MG, Boulton C, Gu TL, Sternberg DW, Neuberg D, Griffin JD, Gilliland DG, Neel BG. Mohi MG, et al. Among authors: neel bg. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3130-5. doi: 10.1073/pnas.0400063101. Epub 2004 Feb 19. Proc Natl Acad Sci U S A. 2004. PMID: 14976243 Free PMC article.

3

Critical role for Gab2 in transformation by BCR/ABL.

Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K, Gesbert F, Iwasaki H, Li S, Van Etten RA, Gu H, Griffin JD, Neel BG. Sattler M, et al. Among authors: neel bg. Cancer Cell. 2002 Jun;1(5):479-92. doi: 10.1016/s1535-6108(02)00074-0. Cancer Cell. 2002. PMID: 12124177 Free article.

4

Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.

Mohi MG, Williams IR, Dearolf CR, Chan G, Kutok JL, Cohen S, Morgan K, Boulton C, Shigematsu H, Keilhack H, Akashi K, Gilliland DG, Neel BG. Mohi MG, et al. Among authors: neel bg. Cancer Cell. 2005 Feb;7(2):179-91. doi: 10.1016/j.ccr.2005.01.010. Cancer Cell. 2005. PMID: 15710330 Free article.

5

Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.

Araki T, Mohi MG, Ismat FA, Bronson RT, Williams IR, Kutok JL, Yang W, Pao LI, Gilliland DG, Epstein JA, Neel BG. Araki T, et al. Among authors: neel bg. Nat Med. 2004 Aug;10(8):849-57. doi: 10.1038/nm1084. Epub 2004 Jul 25. Nat Med. 2004. PMID: 15273746

6

The role of Shp2 (PTPN11) in cancer.

Mohi MG, Neel BG. Mohi MG, et al. Among authors: neel bg. Curr Opin Genet Dev. 2007 Feb;17(1):23-30. doi: 10.1016/j.gde.2006.12.011. Epub 2007 Jan 16. Curr Opin Genet Dev. 2007. PMID: 17227708 Review.

7

Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.

Ren SY, Bolton E, Mohi MG, Morrione A, Neel BG, Skorski T. Ren SY, et al. Among authors: neel bg. Mol Cell Biol. 2005 Sep;25(18):8001-8. doi: 10.1128/MCB.25.18.8001-8008.2005. Mol Cell Biol. 2005. PMID: 16135792 Free PMC article.

8

Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.

Chan G, Kalaitzidis D, Usenko T, Kutok JL, Yang W, Mohi MG, Neel BG. Chan G, et al. Among authors: neel bg. Blood. 2009 Apr 30;113(18):4414-24. doi: 10.1182/blood-2008-10-182626. Epub 2009 Jan 29. Blood. 2009. PMID: 19179468 Free PMC article.

9

Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2.

Zhang SQ, Tsiaras WG, Araki T, Wen G, Minichiello L, Klein R, Neel BG. Zhang SQ, et al. Among authors: neel bg. Mol Cell Biol. 2002 Jun;22(12):4062-72. doi: 10.1128/MCB.22.12.4062-4072.2002. Mol Cell Biol. 2002. PMID: 12024020 Free PMC article.

10

Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.

Bentires-Alj M, Neel BG. Bentires-Alj M, et al. Among authors: neel bg. Cancer Res. 2007 Mar 15;67(6):2420-4. doi: 10.1158/0008-5472.CAN-06-4610. Epub 2007 Mar 8. Cancer Res. 2007. PMID: 17347513

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters